Send Message
Home > products > Anti-Tumor > Methotrexate (59-05-2)

Methotrexate (59-05-2)

Product:
Methotrexate
Description:
CAS: 59-05-2; anti-tumor ; arthritis; rheumatoid
Category:
Anti-Tumor
In-stock:
In Stock
Payment Method:
L/C, T/T
Shipping Method:
AIR, Express
Specifications
CAS:
59-05-2
Specification:
CP, EP, In-house, As Required
M.F.:
C20H22N8O5
M.W.:
454.45
Assay:
98%
Shelf Life:
2 Years
Package:
25kg/drum
High Light:

Methotrexate 59-05-2

,

Methotrexate CAS: 59-05-2

,

rheumatoid Methotrexate

Introduction

Methotrexate is a drug used for the treatment of cancer, also known as cytotoxic drugs. In order to reduce its cytotoxicity, it can be used in conjunction with calcium leucovorin. It is primarily used for the treatment of acute leukemia (acute lymphocytic leukemia), breast cancer, malignant mole and choriocarcinoma, head and neck cancer, bone cancer, leukemia, spinal cord meningeal infiltration, lung cancer, reproductive system cancer, liver cancer, refractory psoriasis vulgaris, dermatomyositis, body myositis, ankylosing spondylitis inflammation, Crohn's disease, psoriasis and psoriatic arthritis, Behcet's disease and autoimmune disease.

Methotrexate is an immunosuppressant and can be used for easing the process of rheumatism with a particularly excellent efficacy in treating synovial inflammation of rheumatoid arthritis and is the most frequently used drugs for treating rheumatoid diseases.

 

Methotrexate (59-05-2) 0

 

Product Name: Methotrexate
CAS No.: 59-05-2
Assay: 98%
Specification: CP, EP, In-house, as required
Molecular Formula: C20H22N8O5
Molecular Weight: 454.45
Shelf Life: 2 Years
Package: 25kg/drum

 

Methotrexate (59-05-2) 1

Methotrexate (59-05-2) 2

Methotrexate (59-05-2) 3

Send RFQ
Stock:
In Stock
MOQ: